OpenAlex
PricingAboutJobs
Log inGet started
Work

Treatment after progression in the era of immunotherapy

HTML

Year: 2020
Type: review
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(20)30328-4
Authors: Salem Billan, Orit Kaidar-Person, Ziv Gil
Institutions: Technion – Israel Institute of Technology, Rambam Health Care Campus, Sheba Medical Center
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: immunotherapy, immune checkpoint inhibitors, pseudoprogression, hyperprogression, tumor immune microenvironment, ipilimumab, immune-related adverse events, cancer immunotherapy response
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3090018062
FWCI: 3.671
Cites: 77
Cited by: 219
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security